CHRISTY PAGE: Open Payments
NPI 1215212568 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 91 payments from 19 companies in 2025. Trend: 2023 $1,765 · 2024 $2,050 · 2025 $1,626
Food & beverage: $1,626
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $319 |
| Novo Nordisk Inc | 11 | $209 |
| Lilly USA, LLC | 14 | $209 |
| ABBVIE INC. | 15 | $169 |
| GlaxoSmithKline, LLC. | 9 | $141 |
| PFIZER INC. | 5 | $93 |
| Abbott Laboratories | 5 | $93 |
| Astellas Pharma US Inc | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $59 |
| Insulet Corporation | 1 | $59 |
Products named: MOUNJARO, FARXIGA, UBRELVY, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, Veozah.
Industry payments across OK — which companies pay providers there.
